Business
Currency:USD
2024/Q1
Stock NameRevenueRatio
EXPAREL132.43M79.24%
ZILRETTA25.84M15.46%
iovera°5.03M3.01%
Bupivacaine liposome injectable suspension2.53M1.51%
Royalty revenue1.29M0.77%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
U.S., European Union (E.U.) and United Kingdom (U.K)538.12M79.72%
United States111.1M16.46%
U.S., Canada and Europe19.69M2.92%
Bupivacaine liposome injectable suspension3.34M0.50%
Royalty revenue2.73M0.40%
